Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Ugeskrift for Laeger
|
January 30, 2003
[Atherosclerosis and Chlamydia pneumoniae]
Mikkel M Larsen, Birgitte Mørn, Paul L Andersen, et al.
The Medical Journal of Australia
|
November 14, 2002
Chlamydia pneumoniae and cardiovascular disease
Mikkel M Larsen, Birgitte Moern, Andrew Fuller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 21, 2003
Chlamydia antibody response in healthy volunteers immunized with nonchlamydial antigens: a randomized, double-blind, placebo-controlled study
Stine Johnsen, Paul L Andersen, Gerold Stanek, et al.
Diagnostic Microbiology and Infectious Disease
|
February 20, 2004
The occurrence of Chlamydia pneumoniae, Mycoplasma pneumoniae, and herpesviruses in otitis media with effusion
Merete Storgaard, Britta Tarp, Therese Ovesen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
May 20, 2003
Activation of the respiratory burst by Pneumocystis carinii. Efficiency of different antibody isotypes, complement, lung surfactant protein D, and mannan-binding lectin
Alex L Laursen, Niels S Obel, Uffe Holmskov, et al.
The American Journal of Clinical Nutrition
|
November 10, 2007
Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls
Christian Wejse, Rikke Olesen, Paulo Rabna, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 31, 2009
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial
Christian Wejse, Victor F Gomes, Paulo Rabna, et al.
BMC Infectious Diseases
|
April 20, 2010
Tuberculosis burden in an urban population: a cross sectional tuberculosis survey from Guinea Bissau
Morten Bjerregaard-Andersen, Zacarias J da Silva, Pernille Ravn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Ugeskrift for Laeger
|
January 30, 2003
[Atherosclerosis and Chlamydia pneumoniae]
Mikkel M Larsen, Birgitte Mørn, Paul L Andersen, et al.
The Medical Journal of Australia
|
November 14, 2002
Chlamydia pneumoniae and cardiovascular disease
Mikkel M Larsen, Birgitte Moern, Andrew Fuller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 21, 2003
Chlamydia antibody response in healthy volunteers immunized with nonchlamydial antigens: a randomized, double-blind, placebo-controlled study
Stine Johnsen, Paul L Andersen, Gerold Stanek, et al.
Diagnostic Microbiology and Infectious Disease
|
February 20, 2004
The occurrence of Chlamydia pneumoniae, Mycoplasma pneumoniae, and herpesviruses in otitis media with effusion
Merete Storgaard, Britta Tarp, Therese Ovesen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
May 20, 2003
Activation of the respiratory burst by Pneumocystis carinii. Efficiency of different antibody isotypes, complement, lung surfactant protein D, and mannan-binding lectin
Alex L Laursen, Niels S Obel, Uffe Holmskov, et al.
The American Journal of Clinical Nutrition
|
November 10, 2007
Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls
Christian Wejse, Rikke Olesen, Paulo Rabna, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 31, 2009
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial
Christian Wejse, Victor F Gomes, Paulo Rabna, et al.
BMC Infectious Diseases
|
April 20, 2010
Tuberculosis burden in an urban population: a cross sectional tuberculosis survey from Guinea Bissau
Morten Bjerregaard-Andersen, Zacarias J da Silva, Pernille Ravn, et al.
Page
of 1